BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 28655772)

  • 1. Post-translational modification of the membrane type 1 matrix metalloproteinase (MT1-MMP) cytoplasmic tail impacts ovarian cancer multicellular aggregate dynamics.
    Yang J; Kasberg WC; Celo A; Liang Z; Quispe K; Stack MS
    J Biol Chem; 2017 Aug; 292(32):13111-13121. PubMed ID: 28655772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination.
    Moss NM; Barbolina MV; Liu Y; Sun L; Munshi HG; Stack MS
    Cancer Res; 2009 Sep; 69(17):7121-9. PubMed ID: 19706774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.
    Klymenko Y; Kim O; Loughran E; Yang J; Lombard R; Alber M; Stack MS
    Oncogene; 2017 Oct; 36(42):5840-5851. PubMed ID: 28628116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane-type I matrix metalloproteinase-dependent ectodomain shedding of mucin16/ CA-125 on ovarian cancer cells modulates adhesion and invasion of peritoneal mesothelium.
    Bruney L; Conley KC; Moss NM; Liu Y; Stack MS
    Biol Chem; 2014 Oct; 395(10):1221-31. PubMed ID: 25205731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the membrane type 1 matrix metalloproteinase cytoplasmic tail enhances tumor cell invasion and proliferation in three-dimensional collagen matrices.
    Moss NM; Wu YI; Liu Y; Munshi HG; Stack MS
    J Biol Chem; 2009 Jul; 284(30):19791-9. PubMed ID: 19458085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor-mediated membrane type 1 matrix metalloproteinase endocytosis regulates the transition between invasive versus expansive growth of ovarian carcinoma cells in three-dimensional collagen.
    Moss NM; Liu Y; Johnson JJ; Debiase P; Jones J; Hudson LG; Munshi HG; Stack MS
    Mol Cancer Res; 2009 Jun; 7(6):809-20. PubMed ID: 19509114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microenvironmental regulation of membrane type 1 matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1 expression.
    Barbolina MV; Adley BP; Ariztia EV; Liu Y; Stack MS
    J Biol Chem; 2007 Feb; 282(7):4924-4931. PubMed ID: 17158885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src-dependent phosphorylation of membrane type I matrix metalloproteinase on cytoplasmic tyrosine 573: role in endothelial and tumor cell migration.
    Nyalendo C; Michaud M; Beaulieu E; Roghi C; Murphy G; Gingras D; Béliveau R
    J Biol Chem; 2007 May; 282(21):15690-9. PubMed ID: 17389600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane type 1 matrix metalloproteinase (MT1-MMP) ubiquitination at Lys581 increases cellular invasion through type I collagen.
    Eisenach PA; de Sampaio PC; Murphy G; Roghi C
    J Biol Chem; 2012 Mar; 287(14):11533-45. PubMed ID: 22315223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling.
    Zhang D; Brodt P
    Oncogene; 2003 Feb; 22(7):974-82. PubMed ID: 12592384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of membrane type 1-matrix metalloproteinase (MT1-MMP) and its vesicle-associated membrane protein 7 (VAMP7)-dependent trafficking facilitate cell invasion and migration.
    Williams KC; Coppolino MG
    J Biol Chem; 2011 Dec; 286(50):43405-16. PubMed ID: 22002060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia promotes HO-8910PM ovarian cancer cell invasion via Snail-mediated MT1-MMP upregulation.
    Sun L; Lin P; Qin Z; Liu Y; Deng LL; Lu C
    Exp Biol Med (Maywood); 2015 Nov; 240(11):1434-45. PubMed ID: 25681470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LIMK Regulates Tumor-Cell Invasion and Matrix Degradation Through Tyrosine Phosphorylation of MT1-MMP.
    Lagoutte E; Villeneuve C; Lafanechère L; Wells CM; Jones GE; Chavrier P; Rossé C
    Sci Rep; 2016 Apr; 6():24925. PubMed ID: 27116935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttranslational regulation of membrane type 1-matrix metalloproteinase (MT1-MMP) in mouse PTEN null prostate cancer cells: Enhanced surface expression and differential O-glycosylation of MT1-MMP.
    Kim S; Huang W; Mottillo EP; Sohail A; Ham YA; Conley-Lacomb MK; Kim CJ; Tzivion G; Kim HR; Wang S; Chen YQ; Fridman R
    Biochim Biophys Acta; 2010 Nov; 1803(11):1287-97. PubMed ID: 20620173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syndecan-2 cytoplasmic domain up-regulates matrix metalloproteinase-7 expression via the protein kinase Cγ-mediated FAK/ERK signaling pathway in colon cancer.
    Jang B; Jung H; Choi S; Lee YH; Lee ST; Oh ES
    J Biol Chem; 2017 Sep; 292(39):16321-16332. PubMed ID: 28821612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous Cadherin Expression and Multicellular Aggregate Dynamics in Ovarian Cancer Dissemination.
    Klymenko Y; Johnson J; Bos B; Lombard R; Campbell L; Loughran E; Stack MS
    Neoplasia; 2017 Jul; 19(7):549-563. PubMed ID: 28601643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of MT1-MMP activity by β-catenin in MDCK non-cancer and HT1080 cancer cells.
    Liu P; Yang J; Pei J; Pei D; Wilson MJ
    J Cell Physiol; 2010 Nov; 225(3):810-21. PubMed ID: 20589835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intradomain cleavage of inhibitory prodomain is essential to protumorigenic function of membrane type-1 matrix metalloproteinase (MT1-MMP) in vivo.
    Golubkov VS; Chernov AV; Strongin AY
    J Biol Chem; 2011 Sep; 286(39):34215-23. PubMed ID: 21832072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.
    Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS
    Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism.
    D'Alessio S; Ferrari G; Cinnante K; Scheerer W; Galloway AC; Roses DF; Rozanov DV; Remacle AG; Oh ES; Shiryaev SA; Strongin AY; Pintucci G; Mignatti P
    J Biol Chem; 2008 Jan; 283(1):87-99. PubMed ID: 17991754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.